Comment on CMS-2026-1255-0001
American Society of HematologySupportAdvocacy
Summary: The American Society of Hematology (ASH) supports the proposed rule to include drugs in prior authorization interoperability requirements to reduce administrative burdens and improve patient access to therapies. They advocate for standardized documentation, human oversight in AI decision-making, and faster turnaround times for urgent clinical situations.
See attached file(s)